Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antiplatelet and Anticoagulant Agents for Secondary Prevention of Stroke and Other Thromboembolic Events in People With Antiphospholipid Syndrome." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/_________Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome______.
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/_________Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome______. Accessed December 12, 2024.
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/_________Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome______
Antiplatelet and Anticoagulant Agents for Secondary Prevention of Stroke and Other Thromboembolic Events in People With Antiphospholipid Syndrome [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 December 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/_________Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
ID - 1305201
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/_________Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -